These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7017181)

  • 1. Research with immunoactive agents.
    Gunby P
    JAMA; 1981 Jul; 246(3):205. PubMed ID: 7017181
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic reconstitution of patients with primary immunodeficiency diseases and cancer after treatment with thymosin.
    Goldstein AL; Thurman GB; Rossio JL; Costanzi JJ
    Transplant Proc; 1977 Mar; 9(1):1141-4. PubMed ID: 325742
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymosin for immunodeficiency diseases and cancer.
    Goldstein AL; Rossio JL
    Compr Ther; 1978 Feb; 4(2):49-57. PubMed ID: 624213
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential role of thymosin in the treatment of autoimmune diseases.
    Goldstein AL; Zatz MM; Low TL; Jacobs R
    Ann N Y Acad Sci; 1981; 377():486-95. PubMed ID: 6462093
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymosin: basic properties and clinical application in the treatment of immunodeficiency diseases and cancer.
    Marshall GD; Thurman GB; Low TL; Goldstein AL
    Recent Results Cancer Res; 1980; 75():100-5. PubMed ID: 6262885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell stimulator undergoes diverse testing.
    Gunby P
    JAMA; 1982 Aug; 248(7):807. PubMed ID: 7047781
    [No Abstract]   [Full Text] [Related]  

  • 8. [Regular trisomy 21 and combined immunodeficiency. Ineffectiveness of thymosin].
    Calvani M; Aiuti F; Felici N; D'Amelio R; Picchio E
    Minerva Pediatr; 1979 Dec; 31(23):1691-7. PubMed ID: 162325
    [No Abstract]   [Full Text] [Related]  

  • 9. Thymosin therapy in the DiGeorge syndrome.
    Barrett DJ; Wara DW; Ammann AJ; Cowan MJ
    J Pediatr; 1980 Jul; 97(1):66-71. PubMed ID: 7381650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease.
    Wara DW; Barrett DJ; Ammann AJ; Cowan MJ
    Ann N Y Acad Sci; 1979; 332():128-34. PubMed ID: 161150
    [No Abstract]   [Full Text] [Related]  

  • 12. Thymosin: basic properties and clinical potential in the treatment of patients with immunodeficiency diseases and cancer.
    Goldstein AL
    Antibiot Chemother (1971); 1978; 24():47-59. PubMed ID: 350140
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of thymosin fractions on the development of compression edema-swelling of the brain].
    Platonov IA
    Eksp Klin Farmakol; 1998; 61(4):51-3. PubMed ID: 9783111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymalfasin: an immune system enhancer for the treatment of liver disease.
    Sjogren MH
    J Gastroenterol Hepatol; 2004 Dec; 19(12):S69-72. PubMed ID: 15641207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results and prospects of using thymosin for the purpose of regulating the immune system in different pathological processes and states].
    Grinevich IuA; Kamenets LIa
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):9-15. PubMed ID: 390944
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of thymosin-alpha 1 therapy for chronic hepatitis D.
    Zavaglia C; Bottelli R; Smedile A; Iamoni G; Mondazzi L; Airoldi A; Lanzani F; Idéo G
    J Clin Gastroenterol; 1996 Sep; 23(2):162-3. PubMed ID: 8877652
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
    Liaw YF
    J Gastroenterol Hepatol; 2004 Dec; 19(12):S73-5. PubMed ID: 15641208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoparathyroidism with T-cell deficiency and hypoimmunoglobulinemia: response to thymosin therapy.
    Bonagura VR; Pitt J
    Clin Immunol Immunopathol; 1981 Mar; 18(3):375-86. PubMed ID: 6972840
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of thymus preparations in treating patients with rheumatic diseases].
    Svintsitskiĭ AS
    Ter Arkh; 1991; 63(5):137-40. PubMed ID: 1887397
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological response modifiers and their promise in clinical medicine.
    Attallah AM; Yeatman TJ; Johnson RP; Petricciani JC
    Pharmacol Ther; 1982; 19(3):435-54. PubMed ID: 6201933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.